Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Genetic Testing for Hereditary Thrombophilia | Retired |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis | Retired |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Biomarker Testing for Risk Stratification in DCIS | Retired |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Molecular Testing for Solid Organ Allograft Rejection | Retired |
| Oct 24, 2026 | WPS Government Health Administrators | Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Retired |
| Oct 24, 2026 | WPS Government Health Administrators | Transurethral Waterjet Ablation of the Prostate | Retired |
| Oct 24, 2026 | WPS Government Health Administrators | Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) | Retired |
| Oct 24, 2026 | WPS Government Health Administrators | Botulinum Toxin Injections | Retired |
| Oct 24, 2026 | WPS Government Health Administrators | MolDx: Molecular Testing for Solid Organ Allograft Rejection | Retired |
| Oct 24, 2026 | WPS Government Health Administrators | Allergy Testing | Retired |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | Retired |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Biomarker Testing for Risk Stratification in DCIS | Retired |
| Oct 24, 2026 | WPS Government Health Administrators | Transurethral Waterjet Ablation of the Prostate | Retired |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | Retired |
| Oct 24, 2026 | WPS Government Health Administrators | Allergy Testing | Retired |
| Oct 24, 2026 | WPS Government Health Administrators | Allergy Diagnostic Testing | Codes changed |
| Oct 24, 2026 | WPS Government Health Administrators | Allergy Diagnostic Testing | New policy |
| Oct 24, 2026 | WPS Government Health Administrators | Peripheral Nerve Injections and Procedures for Chronic Pain | Codes changed |
| Oct 24, 2026 | WPS Government Health Administrators | Peripheral Nerve Injections and Procedures for Chronic Pain | New policy |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer | Codes changed |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer | New policy |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Genetic Testing for Hereditary Thrombophilia | Codes changed |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Genetic Testing for Hereditary Thrombophilia | New policy |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis | Codes changed |
| Oct 24, 2026 | WPS Government Health Administrators | Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Genetic Testing for Heritable Thoracic Aortic Disease | Codes changed |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Genetic Testing for Heritable Thoracic Aortic Disease | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Codes changed |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) | Codes changed |
| Oct 24, 2026 | WPS Government Health Administrators | Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | Total Joint Arthroplasty | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | Botulinum Toxin Injections | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | Micro-Invasive Glaucoma Surgery (MIGS) | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | Cataract Surgery | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | Cervical Fusion | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | Trigger Point Injections | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | Intraarticular Knee Injections of Hyaluronan | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | Sacroiliac Joint Injections and Procedures | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia | Metadata changed |
| Oct 24, 2026 | WPS Government Health Administrators | Epidural Steroid Injections for Pain Management | Metadata changed |